Over one-year follow-up, the patients with a lower both Galectin-3 levels (<15 ng/ml) and left atrium diameter (less than 40 mm) initially, had a 1-year better arrhythmia-free survival rate of 91%, after a single procedure and without administration of an arrhythmic drug. Here, LGALS3 is linked to cardiac arrhythmia.